Valneva Stock (NASDAQ: VALN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.000 / 9.680K |
Day Range | - - - |
52 Wk Range | 6.580 - 17.050 |
Market Cap | $533.650M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 0.07% |
Days to Cover | 4.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Valneva (NASDAQ: VALN) through any online brokerage.
Other companies in Valneva’s space includes: Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO), Altimmune (NASDAQ:ALT), Fate Therapeutics (NASDAQ:FATE) and AnaptysBio (NASDAQ:ANAB).
The latest price target for Valneva (NASDAQ: VALN) was reported by Guggenheim on Friday, March 22, 2024. The analyst firm set a price target for 17.00 expecting VALN to rise to within 12 months (a possible 121.64% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Valneva (NASDAQ: VALN) is $7.67 last updated April 22, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Valneva.
Valneva’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Valneva.
Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.